Le Lézard
Classified in: Science and technology
Subject: Funding

Minority Health Focused Startup Mae Closes Oversubscribed Seed Funding Round to Reduce Maternal Health Disparities


Mae Health Inc, announces the close of a seed raise, led by Jumpstart Nova, to scale its tech-enabled services offering to drive improvements in Black maternal health outcomes. Mae's round also included participation from new investors including the Astia Fund, Impact Engine, Joyance Partners, and Gratitude Railroad, and early investors RH Capital, Avestria Ventures, Bright Ventures, and the Social Starts Health & Happiness Fund.

Black Americans face a maternal mortality rate more than two and half times higher than other demographic groups. The U.S. has also seen an alarming increase in maternity care deserts, with an estimated 16% of Black babies born in areas with limited or no access to maternity care services. Mae's oversubscribed seed raise, enabling the company to scale while combating these disparities, comes at a critical time as the country continues to face rising maternal and infant mortality rates.

Mae combines a digital engagement and risk-tracking platform with community-based doula support to better align provider support teams and center the pregnant person throughout the perinatal journey, all with the goal of reducing disparate maternal health outcomes, including preterm births and non-medically necessary C-sections.

Mae is already making an impact:

"Since our founding, our goal at Mae has been to create more seamless pathways for established, impactful clinical interventions to reach more birthing people of color, and we're thrilled by the progress we've made in our earliest years. We are grateful for the partnership of Jumpstart Nova and our growing community of investors in believing deeply in this mission, and working collaboratively with us to drive towards improvements in maternal health equity," says Mae's founder and CEO, Maya Hardigan.

Notably, Mae has prioritized Medicaid partnerships, as Medicaid covers nearly half of all births and upwards of 65% of Black births nationally. Mae partners with states and Managed Care Organizations to deploy innovative maternal health initiatives and newly established regulatory changes, including providing support and coverage through 12 months postpartum and promoting fully covered doula benefits to individuals covered under Medicaid.

"Venture capital has an outsized influence on which healthcare ideas and problems are perceived as worth funding and will make money. Saving Black mothers is worth funding and investing in Mae will generate significant returns. Despite over $50 billion USD invested in the U.S. pregnancy care market, total morbidity costs for all U.S. births are estimated to be $32 billion USD and many of these costs are avoidable. We are failing our mothers. Mae has created a culturally competent care model fit for diverse patient populations, a growing population that represents nearly half of the births in the U.S."
Kathryne Cooper, Partner, Jumpstart Nova

Mae is equally committed to increasing the overall doula provider workforce and works to support doulas interested in Medicaid participation through registrations and ongoing administrative support in serving Medicaid beneficiaries. Doulas are a critical support in advocating for birthing people and improving pregnancy experiences and outcomes.

According to Angelene Love, a community-based doula in Michigan with whom Mae is partnered, "The support that Mae offers both families and doulas is unmatched. Mae provides educational support that they otherwise would not have access to, and I've been able to amplify my reach to provide more families with doula support."

With this funding, Mae will continue to harness the collective expertise of community-based stakeholders, managed care organizations, and state Departments of Health to drive meaningful change for Black mothers, their communities, and the birth workers supporting them.

About Mae

Mae is a culturally responsive digital first solution built to address the specific clinical, social, and cultural needs of underserved expectant mothers, with an early focus on Black expectant mothers, those with the most striking disparities in maternal health outcomes. Mae has created a space where complete digital care meets culturally aligned on-the-ground doula support. For more information, please visit meetmae.com.

??About Jumpstart Nova

Jumpstart Nova is the first venture fund in America to invest exclusively in Black founded and led healthcare companies at the forefront of innovation. That was only the beginning. Jumpstart Nova Fund I invests in seed and Series A stage companies in the areas of tech-enabled services, biotech, diagnostic devices, health IT, digital health, and consumer health & wellness. The fund is strategically backed by leading healthcare organizations in the US such as Eli Lilly and Company, HCA Healthcare, Cardinal Health, Atrium Health, Henry Ford Health System, LHC Group, Meharry Medical College, and American Hospital Association. For more information, please visit jumpstartnova.com.


These press releases may also interest you

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: